Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Please check back later for more content.

Dosage Forms

Reshaping Dosage Forms

Frontrunners in Bispecific Antibodies

Trending on Pharmaceutical Technology

CAR T-Cell Trial Pause Signals New Manufacturing Risk Review

What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation

An Introduction to CPHI Milan 2026

AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1

AAPS PharmSci 360: CMC Strategies, Part 1